Collage photo of Jia Liu and Elizabeth Smyth
Jul 20, 2025, 18:39
Jia Liu: Elizabeth Smyth Gives Insightful Summary in Novel ADCs at ESMO TAT Asia 2025
Jia Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared a post on LinkedIn:
“Prof Elizabeth Smyth giving insightful summary in novel ADCs including payload diversification via immune-stimulation, degraders, Immuno toxins, and the challenges with stromal targeting ADCs.
Biospecific ADCs hitting clinics and target selection, biomarkers and translational studies done alongside well-designed dose optimization clinical trials with collaboration required.”
More posts featuring Jia Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 20:58
Aug 25, 2025, 20:44
Aug 25, 2025, 20:33
Aug 25, 2025, 19:54
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36